Navigation Links
Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
Date:9/18/2007

Medical Device Provides Rapid In-hospital Hypothermia Therapy

ALEXANDRIA, La., Sept. 18 /PRNewswire/ -- Life Recovery Systems, HD, LLC, of Alexandria, LA and Kinnelon, NJ, an emerging provider of groundbreaking medical devices for the emergency medical care market, announced today that its ThermoSuit(R) System has been granted European CE Mark (Conformite Europeene) approval for Temperature reduction in patients where clinically indicated, e.g., to induce hypothermia in patients to preserve cardiac and brain function in victims of cardiac arrest, stroke, heart attack, traumatic brain injury and hyperthermic patients.

The ThermoSuit System uses innovative technology to rapidly cool a patient's core temperature. It consists of a disposable body suit and a means to pump coolant within the suit over the skin of the patient. It is the first device for patient temperature management that conveniently provides a thin layer of rapidly flowing liquid coolant in direct contact with the skin. This approach gives the ThermoSuit System outstanding capabilities to rapidly and non-invasively change patient temperature. It has been designed for ease of use for clinicians who treat patients indicated for cooling therapy, and has the potential to quickly cool these patients conveniently and rapidly.

"European CE Mark approval of the ThermoSuit System is an important next step in achieving our company's mission," said John DiLiddo, Life Recovery Systems' Vice President of Marketing and Sales. "With the introduction in Europe of the ThermoSuit System for use in the hospital, physicians and nurses will now have a convenient, easy-to-use tool in the delivery of emergency hypothermia therapy."

Evolving International standards of care recommend that "unconscious adult patients with spontaneous circulation after out-of-hospital cardiac arrest should be cooled to 32 degrees C to 34 degrees C for 12-24 hours when the initial rhythm was ventricular fibrillation. Such cooling may also be beneficial for other rhythms or in-hospital cardiac arrest."

Life Recovery Systems, HD, LLC is focused on developing and providing groundbreaking, innovative medical devices for the emergency medical care market. To learn more, visit http://www.life-recovery.com.


'/>"/>
SOURCE Life Recovery Systems, HD, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
2. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine
3. ProtoKinetixs AAGP Dramatically Increases Recovery Rate of Cryopreserved Stem Cells
4. CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies
5. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
6. When Volume Matters, Immunoassay Systems Deliver
7. Genetic Analysis Systems Enter the Clinical Mainstream
8. New Quality Control Systems for Every Laboratory Application
9. Immunoassay Systems - Your Laboratory Workhorse
10. SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus Drug-Eluting Coronary Stent Systems
11. Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)...  Lannett Company, Inc. (NYSE: LCI ) today announced ... Prescription for Success Healthcare Conference on December 14, 2016 at 9:20 ... York City . In addition, the company will ... 4 th Annual Boston Healthcare Conference taking place on December ... ...
(Date:12/6/2016)... CONCORD, Mass. , Dec. 6, 2016  Alopexx ... of DI-Leu16-IL2, a recombinant antibody fusion protein (immunocytokine) composed ... antibody recognizes the same target on B cells as ... and cytokine components but is also involved in tumor ... an anti-cancer vaccine effect. The results of the study ...
(Date:12/6/2016)... , Dec. 6, 2016 Diabetes & Obesity ... diabetes and obesity disease cluster is currently dominated by ... type 2 diabetes mellitus (T2DM), and the majority of ... of products, is attributable to these indications. While products ... market presence, there are a large number of these ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any ... useful, properly analyzed data. The team at Beckman Coulter has designed Kaluza, templates with ... speed' and the need to operate in a GLP (Good Laboratory Practice) fashion. , ...
(Date:12/7/2016)... ... 2016 , ... When it came time to blow out his candles on his 14th birthday, ... Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his family with a ... heart transplant recipient. , “He was playing at home, when we got the phone ...
(Date:12/7/2016)... PITTSBURGH, PA (PRWEB) , ... December 07, 2016 , ... ... and regular changing of the securement tape is painful for her. "This is why ... cannula’s to patients’ heads," she said. , They then created a prototype of the ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... to announce that its fully redesigned website, which launched October 17, 2016, features ... sleek responsive design and easy-to-navigate layout. Visitors and patients can discover the latest ...
(Date:12/7/2016)... Studio City, CA (PRWEB) , ... December 07, 2016 , ... ... number during the holidays and winter seasons. One major study analyzing heart attacks ... January compared to August of a given year. We would all agree of course–no ...
Breaking Medicine News(10 mins):